COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases

Title:COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases

Volume: 21 Issue: 6

Author(s): Fereshteh Ghiasvand, Maryam Ghadimi, Sara Sadr, Fatemeh Jafari, Navid Manafi, Zahra Ahmadinejad, Samaneh Tirgar and Seyed Ahmad Seyed Alinaghi*

Affiliation:

• Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran,,Iran

Keywords: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), hydroxychloroquine, azithromycin, atazanavir, ritonavir.

Abstract: Background: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy.

Case Presentation: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.

Conclusion: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19.

Cite this article as:

Ghiasvand Fereshteh , Ghadimi Maryam , Sadr Sara , Jafari Fatemeh , Manafi Navid , Ahmadinejad Zahra , Tirgar Samaneh and Seyed Alinaghi Seyed Ahmad *, COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases, Infectious Disorders - Drug Targets 2021; 21(6) : e170721188439 . https://dx.doi.org/10.2174/1871526520999201126203510